TABLE 4.
Overall | White | Black | Hispanic | |||
---|---|---|---|---|---|---|
% (95% CI) | % (95% CI) | % (95% CI) | P (vs. White) | % (95% CI) | P (vs. White) | |
A1C | ||||||
Individualized† | 65 (61-69) | 68 (63-73) | 64 (59-69) | 0.30 | 56 (50-62) | <0.001 |
< 6.5% | 45 (32-59) | 49 (32-72) | 38 (15-61) | 0.51 | 40 (17-63) | 0.57 |
< 7.0% | 50 (42-58) | 51 (39-62) | 63 (42-63) | 0.78 | 47 (39-54) | 0.56 |
< 8.0% | 79 (76-82) | 81 (77-85) | 76 (71-81) | 0.08 | 69 (62-76) | 0.003 |
Uniform A1C< 7.0% | 52 (47-57) | 53 (47-60) | 52 (46-57) | 0.08 | 46 (39-52) | 0.07 |
Uniform A1C< 8.0% | 77 (74-80) | 80 (76-84) | 74 (70-78) | 0.02 | 69 (63-75) | <0.001 |
LDL | ||||||
Individualized‡ | 46 (41-51) | 51 (45-59) | 31 (23-38) | <0.001 | 36 (28-44) | 0.004 |
< 70 mg/dL | 28 (18-38) | 33 (21-45) | 10 (1-19) | 0.003 | 19 (11-27) | 0.006 |
< 100 mg/dL | 52 (46-58) | 58 (49-68) | 37 (28-45) | 0.001 | 41 (31-50) | 0.01 |
Uniform LDL < 100 mg/dL | 55 (51-60) | 62 (55-69) | 39 (30-48) | <0.001 | 43 (35-50) | <0.001 |
Any statin use | 52 (49-56) | 56 (51-62) | 45 (39-51) | 0.01 | 44 (41-48) | <0.001 |
Blood pressure <140/90 | 65 (61-69) | 69 (63-74) | 53 (48-59) | <0.001 | 66 (61-71) | 0.45 |
Nonsmoking§ | 72 (69-75) | 73 (69-77) | 64 (59-68) | <0.001 | 81 (78-84) | 0.004 |
Comprehensive | ||||||
Individualized A1C, individualized LDL, BP < 140/90, nonsmoking | 18 (15-21) | 22 (17-27) | 6 (2-11) | <0.001 | 11 (6-15) | 0.005 |
Uniform A1C < 7%, uniform LDL < 100 mg/dL, BP < 140/90, nonsmoking | 16 (12-20) | 19 (13-26) | 7 (3-11) | 0.006 | 13 (9-17) | 0.09 |
Uniform A1C < 8%, uniform LDL < 100 mg/dL, BP < 140/90, nonsmoking | 25 (21-30) | 31 (24-39) | 11 (6-15) | <0.001 | 17 (11-23) | 0.007 |
Results are weighted to represent the US population. Data are expressed as % (95% CI).
Individualized A1C assigned to patients based on age, duration of diabetes, diabetic complication history, and comorbidity. See Table 1 for details.
Individualized LDL < 70 mg/dL goal assigned to patients with a history of cardiovascular disease. Other patients were assigned the <100 mg/dL goal.
Nonsmoking defined by self-report and a serum cotinine < 10 ng/mL.